Aino Health AB (publ) (STO:AINO)
Sweden · Delayed Price · Currency is SEK 0.1950
0.00 (0.00%)
Jul 21, 2026, 1:00 PM CET
Aino Health AB Revenue
Aino Health AB had revenue of 5.54M SEK in the quarter ending March 31, 2026, a decrease of -25.02%. This brings the company's revenue in the last twelve months to 24.27M, down -4.17% year-over-year. In the year 2025, Aino Health AB had annual revenue of 26.12M with 8.87% growth.
Revenue (ttm)
24.27M
Revenue Growth
-4.17%
P/S Ratio
1.64
Revenue / Employee
1.35M
Employees
18
Market Cap
39.89M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.12M | 2.13M | 8.87% |
| Dec 31, 2024 | 23.99M | -1.08M | -4.31% |
| Dec 31, 2023 | 25.07M | 5.02M | 25.02% |
| Dec 31, 2022 | 20.05M | -3.05M | -13.18% |
| Dec 31, 2021 | 23.10M | -2.36M | -9.26% |
| Dec 31, 2020 | 25.46M | -472.00K | -1.82% |
| Dec 31, 2019 | 25.93M | 5.02M | 24.00% |
| Dec 31, 2018 | 20.91M | 1.53M | 7.87% |
| Dec 31, 2017 | 19.39M | 13.06M | 206.68% |
| Dec 31, 2016 | 6.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.24B |
| Swedish Orphan Biovitrum AB | 28.96B |
| Sectra AB | 3.65B |
| Camurus AB | 2.27B |
| Magle Chemoswed Holding AB | 273.25M |
| ScandiDos AB | 58.09M |
| Fluicell AB | 20.15M |
| ExpreS2ion Biotech Holding AB | 16.12M |
Aino Health AB News
- 2 months ago - Aino Health AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Aino Health AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Aino Health AB Annual report: Q4 2025 - Filings
- 9 months ago - Aino Health AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Aino Health AB Quarterly report: Q2 2025 - Filings